Mono Vaccine Market Report 2031 | The Insight Partners
The Mono Vaccine Market is expected to register a CAGR of 8.9% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented By Application (Mononucleosis, Endemic Burkitts lymphoma, Hodgkins lymphoma, Gastric carcinomas, Multiple sclerosis, Nasopharyngeal, Carcinoma); End user (Adults, Children). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Mono Vaccine Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Mono Vaccine Market Segmentation
Application- Mononucleosis
- Endemic Burkitts lymphoma
- Hodgkins lymphoma
- Gastric carcinomas
- Multiple sclerosis
- Nasopharyngeal
- Carcinoma
- Adults
- Children
Strategic Insights
Mono Vaccine Market Growth Drivers- World-Wide Increased Government Vaccination Programs: Almost all government vaccination programs have been taken on in recent years to control infectious diseases at a worldwide scale. Oftentimes, these programs are for mono vaccines because they are very specific to specific pathogens, giving them a higher efficacy level against disease control. Also, where the immunization process is improved, increased demand for mono vaccines arises, for example, measles, mumps, and rubella, which is good for market growth.
- The Multinational Health Threat and the Pandemic: International health problems, such as a certain pandemic like the COVID-19 pandemic, have greatly increased the demand for mono vaccines. Target-conferred vaccines can provide efficient protection from a specific virus, and the urgency in creating ad hoc campaigns for very rapid and rapid vaccinations strikes again at the very essence of the dual market growth of the manufacturers. With every disease outbreak, the mono vaccine industry is developing as a response.
- Technological Developments in Vaccine Making: Technological advancements are the most powerful driving engine of the mono vaccine market, and they pertain to vaccine research and development. Such great breakthroughs as mRNA technology allow for developing vaccines at a faster rate and making them so specific that they would confer protection much quicker from a particular pathogen. Such inventions make mono vaccines quite available and efficient, thus gaining more ground across the world.
- World-Wide Increased Government Vaccination Programs: Almost all government vaccination programs have been taken on in recent years to control infectious diseases at a worldwide scale. Oftentimes, these programs are for mono vaccines because they are very specific to specific pathogens, giving them a higher efficacy level against disease control. Also, where the immunization process is improved, increased demand for mono vaccines arises, for example, measles, mumps, and rubella, which is good for market growth.
- The Multinational Health Threat and the Pandemic: International health problems, such as a certain pandemic like the COVID-19 pandemic, have greatly increased the demand for mono vaccines. Target-conferred vaccines can provide efficient protection from a specific virus, and the urgency in creating ad hoc campaigns for very rapid and rapid vaccinations strikes again at the very essence of the dual market growth of the manufacturers. With every disease outbreak, the mono vaccine industry is developing as a response.
- Technological Developments in Vaccine Making: Technological advancements are the most powerful driving engine of the mono vaccine market, and they pertain to vaccine research and development. Such great breakthroughs as mRNA technology allow for developing vaccines at a faster rate and making them so specific that they would confer protection much quicker from a particular pathogen. Such inventions make mono vaccines quite available and efficient, thus gaining more ground across the world.
- Expansion in Developing Market: The mono vaccine market has huge potential in developing countries where people are suffering from serious infectious diseases, and there are a number of unreached population segments in their immunization schedules. Governments of these emerging economies are looking towards boosting their immunization programs. With such high demand markets created in the area, the companies making mono vaccines will be able to reach the needy populations with affordable and easy-access vaccines.
- Combining with the New Technology of Vaccination: Novel vaccine technologies such as mRNA and viral vector platforms might be integrated with mono vaccines. According to the manufacturers, creating more efficient, safer, and quickly deployable mono vaccines through the use of these vault advanced technologies, they would be able to provide highly efficacious solutions for particular diseases with extended therapeutic applications and thereby broadening the market scope for mono vaccines.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Mono Vaccine Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Mono Vaccine Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The market is expected to grow at a CAGR of 8.9%
The North America region accounts for highest revenue share Mono Vaccine Market?
The final report will duly include market size and projection estimates for all the segments from 2021 to 2031, along with a revenue share and compound annual growth rate (%) for the regional
/
country-wise market wherein 2021-2022 are the historic years, 2023 is considered to be the base year, and the forecast will be provided till 2031, along with CAGR (%)
GlaxoSmithKline plc, Sanofi S.A., Pfizer Inc, CNBG, Merck the major companies operating in the Mono Vaccine Market
Asia Pacific is estimated to grow at the highest CAGR over the forecast year (2023 - 2031)
Technological Developments in Vaccine Making is the major factors boosting the Mono Vaccine Market growth
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Mono Vaccine Market - By Application
1.3.2 Mono Vaccine Market - By End user
1.3.3 Mono Vaccine Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MONO VACCINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MONO VACCINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MONO VACCINE MARKET - GLOBAL MARKET ANALYSIS
6.1. MONO VACCINE - GLOBAL MARKET OVERVIEW
6.2. MONO VACCINE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. MONO VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. MONONUCLEOSIS
7.3.1. Overview
7.3.2. Mononucleosis Market Forecast and Analysis
7.4. ENDEMIC BURKITT'S LYMPHOMA
7.4.1. Overview
7.4.2. Endemic Burkitt's lymphoma Market Forecast and Analysis
7.5. HODGKIN'S LYMPHOMA
7.5.1. Overview
7.5.2. Hodgkin's lymphoma Market Forecast and Analysis
7.6. GASTRIC CARCINOMAS
7.6.1. Overview
7.6.2. Gastric carcinomas Market Forecast and Analysis
7.7. MULTIPLE SCLEROSIS
7.7.1. Overview
7.7.2. Multiple sclerosis Market Forecast and Analysis
7.8. NASOPHARYNGEAL
7.8.1. Overview
7.8.2. Nasopharyngeal Market Forecast and Analysis
7.9. CARCINOMA
7.9.1. Overview
7.9.2. Carcinoma Market Forecast and Analysis
8. MONO VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. ADULTS
8.3.1. Overview
8.3.2. Adults Market Forecast and Analysis
8.4. CHILDREN
8.4.1. Overview
8.4.2. Children Market Forecast and Analysis
9. MONO VACCINE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Mono Vaccine Market Overview
9.1.2 North America Mono Vaccine Market Forecasts and Analysis
9.1.3 North America Mono Vaccine Market Forecasts and Analysis - By Application
9.1.4 North America Mono Vaccine Market Forecasts and Analysis - By End user
9.1.5 North America Mono Vaccine Market Forecasts and Analysis - By Countries
9.1.5.1 United States Mono Vaccine Market
9.1.5.1.1 United States Mono Vaccine Market by Application
9.1.5.1.2 United States Mono Vaccine Market by End user
9.1.5.2 Canada Mono Vaccine Market
9.1.5.2.1 Canada Mono Vaccine Market by Application
9.1.5.2.2 Canada Mono Vaccine Market by End user
9.1.5.3 Mexico Mono Vaccine Market
9.1.5.3.1 Mexico Mono Vaccine Market by Application
9.1.5.3.2 Mexico Mono Vaccine Market by End user
9.2. EUROPE
9.2.1 Europe Mono Vaccine Market Overview
9.2.2 Europe Mono Vaccine Market Forecasts and Analysis
9.2.3 Europe Mono Vaccine Market Forecasts and Analysis - By Application
9.2.4 Europe Mono Vaccine Market Forecasts and Analysis - By End user
9.2.5 Europe Mono Vaccine Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Mono Vaccine Market
9.2.5.1.1 Germany Mono Vaccine Market by Application
9.2.5.1.2 Germany Mono Vaccine Market by End user
9.2.5.2 France Mono Vaccine Market
9.2.5.2.1 France Mono Vaccine Market by Application
9.2.5.2.2 France Mono Vaccine Market by End user
9.2.5.3 Italy Mono Vaccine Market
9.2.5.3.1 Italy Mono Vaccine Market by Application
9.2.5.3.2 Italy Mono Vaccine Market by End user
9.2.5.4 Spain Mono Vaccine Market
9.2.5.4.1 Spain Mono Vaccine Market by Application
9.2.5.4.2 Spain Mono Vaccine Market by End user
9.2.5.5 United Kingdom Mono Vaccine Market
9.2.5.5.1 United Kingdom Mono Vaccine Market by Application
9.2.5.5.2 United Kingdom Mono Vaccine Market by End user
9.2.5.6 Rest of Europe Mono Vaccine Market
9.2.5.6.1 Rest of Europe Mono Vaccine Market by Application
9.2.5.6.2 Rest of Europe Mono Vaccine Market by End user
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Mono Vaccine Market Overview
9.3.2 Asia-Pacific Mono Vaccine Market Forecasts and Analysis
9.3.3 Asia-Pacific Mono Vaccine Market Forecasts and Analysis - By Application
9.3.4 Asia-Pacific Mono Vaccine Market Forecasts and Analysis - By End user
9.3.5 Asia-Pacific Mono Vaccine Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Mono Vaccine Market
9.3.5.1.1 Australia Mono Vaccine Market by Application
9.3.5.1.2 Australia Mono Vaccine Market by End user
9.3.5.2 China Mono Vaccine Market
9.3.5.2.1 China Mono Vaccine Market by Application
9.3.5.2.2 China Mono Vaccine Market by End user
9.3.5.3 India Mono Vaccine Market
9.3.5.3.1 India Mono Vaccine Market by Application
9.3.5.3.2 India Mono Vaccine Market by End user
9.3.5.4 Japan Mono Vaccine Market
9.3.5.4.1 Japan Mono Vaccine Market by Application
9.3.5.4.2 Japan Mono Vaccine Market by End user
9.3.5.5 South Korea Mono Vaccine Market
9.3.5.5.1 South Korea Mono Vaccine Market by Application
9.3.5.5.2 South Korea Mono Vaccine Market by End user
9.3.5.6 Rest of Asia-Pacific Mono Vaccine Market
9.3.5.6.1 Rest of Asia-Pacific Mono Vaccine Market by Application
9.3.5.6.2 Rest of Asia-Pacific Mono Vaccine Market by End user
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Mono Vaccine Market Overview
9.4.2 Middle East and Africa Mono Vaccine Market Forecasts and Analysis
9.4.3 Middle East and Africa Mono Vaccine Market Forecasts and Analysis - By Application
9.4.4 Middle East and Africa Mono Vaccine Market Forecasts and Analysis - By End user
9.4.5 Middle East and Africa Mono Vaccine Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Mono Vaccine Market
9.4.5.1.1 South Africa Mono Vaccine Market by Application
9.4.5.1.2 South Africa Mono Vaccine Market by End user
9.4.5.2 Saudi Arabia Mono Vaccine Market
9.4.5.2.1 Saudi Arabia Mono Vaccine Market by Application
9.4.5.2.2 Saudi Arabia Mono Vaccine Market by End user
9.4.5.3 U.A.E Mono Vaccine Market
9.4.5.3.1 U.A.E Mono Vaccine Market by Application
9.4.5.3.2 U.A.E Mono Vaccine Market by End user
9.4.5.4 Rest of Middle East and Africa Mono Vaccine Market
9.4.5.4.1 Rest of Middle East and Africa Mono Vaccine Market by Application
9.4.5.4.2 Rest of Middle East and Africa Mono Vaccine Market by End user
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Mono Vaccine Market Overview
9.5.2 South and Central America Mono Vaccine Market Forecasts and Analysis
9.5.3 South and Central America Mono Vaccine Market Forecasts and Analysis - By Application
9.5.4 South and Central America Mono Vaccine Market Forecasts and Analysis - By End user
9.5.5 South and Central America Mono Vaccine Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Mono Vaccine Market
9.5.5.1.1 Brazil Mono Vaccine Market by Application
9.5.5.1.2 Brazil Mono Vaccine Market by End user
9.5.5.2 Argentina Mono Vaccine Market
9.5.5.2.1 Argentina Mono Vaccine Market by Application
9.5.5.2.2 Argentina Mono Vaccine Market by End user
9.5.5.3 Rest of South and Central America Mono Vaccine Market
9.5.5.3.1 Rest of South and Central America Mono Vaccine Market by Application
9.5.5.3.2 Rest of South and Central America Mono Vaccine Market by End user
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL MONO VACCINE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. MONO VACCINE MARKET, KEY COMPANY PROFILES
12.1. GLAXOSMITHKLINE PLC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. SANOFI S.A.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CNBG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MERCK
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. NEURON BIOTECH
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MSD
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SERUM INSTITUTE OF INDIA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. BIOMED PVT. LTD
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BAXTER INTERNATIONAL
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. GlaxoSmithKline plc
2. Sanofi S.A.
3. Pfizer Inc
4. CNBG
5. Merck
6. Neuron Biotech
7. MSD
8. Serum Institute of India
9. Biomed Pvt. Ltd
10. Baxter International
11. Biokangtai
12. JN-International Medical Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For